首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1624409

全球蜂窩分析市場規模（按產品類型、蜂窩類型、最終用戶、地區、範圍和預測）

Global Cell Analysis Market Size By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells, Microbial Cells), By End-User (Biotechnology Companies, Hospitals, Cell Banks), By Geographic Scope And Forecast

出版日期: 2024年11月18日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

細胞分析市場規模及預測

2021 年細胞分析市場規模價值為 160.7 億美元，預計到 2030 年將達到 383.4 億美元，2023 年至 2030 年的複合年增長率為 10.15%。增加政府對細胞研究的資助是增加細胞分析市場收入的關鍵方面，而單細胞分析產品的技術進步則推動市場成長。全球蜂窩分析市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

定義全球細胞分析市場

細胞分析在單細胞層級研究生物的基因組、代謝組學、轉錄組學和蛋白質組學。單細胞分析用於測量、分析和定序單細胞異質性的人類基因組。螢光活化細胞分選技術從複雜樣本中分離出選定的單細胞。在臨床診斷中，細胞分析有望實現工作流程的標準化和自動化，為癌症的即時監測提供有價值的信息，並最終為患者帶來新的治療策略。

細胞分析對於基因鑑定、蛋白質鑑定、表觀基因組學和其他相關生命科學領域至關重要。提高細胞成像和分析系統的準確性有助於加快藥物研發過程並降低成本。如今，大多數地方都是以批量方式分析細胞，每個樣本包含數千個細胞，並根據細胞的平均反應來分析結果。因此，為了進行實用且精確的細胞分析，必須考慮單一細胞究竟如何反應。

全球細胞分析市場概覽

醫療產業的發展和癌症發生率的上升推動了細胞分析市場的發展。此外，技術先進產品的引進以及醫院、診斷實驗室等的興起也推動了市場的成長。此外，細胞分析在診斷應用的採用越來越多，也是推動全球細胞分析市場發展的關鍵因素。此外，政府對細胞研究的投資和資助不斷增加也是推動全球市場成長的其他因素。

此外，傳染病、慢性病和神經系統疾病的日益普及是推動全球細胞分析市場成長的正面預測。還有一些課題阻礙了整個市場的成長。設備成本高等因素阻礙了市場成長。市場面臨的另一個主要課題是小企業和新進者的生存。然而，體細胞研究和細胞定序的研究和開發預計將為全球細胞分析市場的主要參與者提供豐厚的商機。

Cell Analysis Market size was valued at USD 16.07 Billion in 2021 and is projected to reach USD 38.34 Billion by 2030 , growing at a CAGR of 10.15% from 2023 to 2030. The increasing government funding for cell-based research is the crucial aspect of the rise in the market revenue of Cell Analysis as well as the technological advancements in single-cell analysis products that will foster market growth. The Global Cell Analysis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cell Analysis Market Definition

Cell Analysis studies the genomics, metabolomics, transcriptomics, and proteomics of a living being at a single-cell level. The single-Cell Analysis is used in measuring, analyzing, and sequencing the human genome at a single-cell heterogeneity. Fluorescence-activated cell sorting isolates the selected single cells from complex samples. In clinical diagnostics, Cell Analysis is expected to standardize and automate workflows with valuable information for real-time monitoring of cancer and, eventually, new therapeutic strategies for the benefit of patients.

Cellular Analysis is vital in gene identification, protein identification, epigenomics, and other life science-related areas. Enhanced accuracy of cell imaging and analysis systems helps reduce the drug discovery process time and price. Today in most places, cells are analyzed in masses with thousands of cells per sample, and results are analyzed based on the average response of the cells. Hence to get practical and accurate Cell Analysis, it's essential to review how exactly individual cells respond.

Global Cell Analysis Market Overview

The Growth of the Cell Analysis Market is driven by the development of the healthcare industry and the rise in cancer incidence. Furthermore, the introduction of technologically advanced products and an increased number of hospitals, diagnostic laboratories, and others fuel the market growth. Moreover, increasing the adoption of Cell Analysis for diagnostic applications is a significant factor driving the development of the global Cell Analysis Market. Moreover, rising government investments and funding for cell-based research are other factors fueling the growth of the worldwide market.

Moreover, the increasing prevalence of infectious & chronic diseases and neurological disorders has positively anticipated propelling the growth of the global Cell Analysis Market. There are specific challenges faced that will hinder the overall market growth. Factors such as the high cost of instruments inhibit the market's growth. Also, the survival of small players and new entrants is the major challenge faced by the market. However, research and development in somatic cell research and cell sequencing may be expected to present lucrative business opportunities for major players within the global Cell Analysis Market.

Global Cell Analysis Market Segmentation Analysis

The Global Cell Analysis Market is segmented based on Product, Cell Type, End-User, And Geography.

Cell Analysis Market, By Product

Consumables
Instruments

Based on Product, the market is bifurcated into Consumables and Instruments. The consumables segment holds the largest market share during the forecast period. The factors that can be attributed to the frequent purchase of these products as compared to instruments, which are considered as a one-time investment, and their wide applications in research and genetic exploration, exosome analysis, and isolation of RNA and DNA are accelerating the demand for consumables segment.

Cell Analysis Market, By Cell Type

Human Cells
Animal Cells
Microbial Cells

Based on Cell Type, the market is bifurcated into Human Cells, Animal Cells, and Microbial Cells. The human cells segment holds the largest market share. The factors that can be attributed to the high utilization of human cells in research laboratories and academic institutes are accelerating the demand.

Cell Analysis Market, By End-User

Biotechnology Companies
Hospitals
Cell Banks
Others

Based on End-User, the market is bifurcated into Biotechnology Companies, Hospitals, Cell Banks, and Others. The academic and research laboratories segment holds the largest market share during the forecast period. The factors that can be attributed to growth in funding for all times science research and therefore the increasing number of medical colleges and universities enhance the demand for academic and research laboratories segment.

Cell Analysis Market, By Geography

North America
Europe
Asia Pacific
Rest of The World
On the basis of Geography, the Global Cell Analysis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia-Pacific holds the largest market share. The Asia Pacific market is anticipated to witness the highest growth during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, growth in the outsourcing of drug discovery services to Asian CROs, strong governmental initiatives, and ongoing projects will boost the market in the APAC region.

Key Players

The "Global Cell Analysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Becton, Dickinson and Company, Merck KGAA, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Agilent Technologies, Inc., Olympus Corporation, Perkinelmer, Inc., Promega Corporation, and Tecan Group Ltd.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

Product Launches and Product Expansions
In April 2018, BD (Becton, Dickinson and Business), a leading worldwide medical technology company, announced the launch of the BD FACSymphony(TM) S6 cell sorter, which will be on exhibit at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform takes advantage of the BD FACSymphony cell analyzer's high parameter capabilities, allowing researchers to sort cell populations to better understand cell phenotypes for immunology and multi-omics research.
In May 2018, Beckman Coulter Life Sciences introduced the Kaluza C Flow Cytometry Analysis Software, a sophisticated data analysis system for clinical laboratories. The new program simplifies clinical QC reporting and addresses flow cytometry standardization difficulties.
In September 2018, Leica Microsystems established the first Imaging Center in San Francisco. This facility will showcase the spectrum of technology in microscopes produced by Leica Microsystems for life sciences research.

1 INTRODUCTION OF GLOBAL CELL ANALYSIS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL CELL ANALYSIS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL CELL ANALYSIS MARKET, BY PRODUCT

5.1 Overview
5.2 Consumables
- 5.2.1 Reagents
- 5.2.2 Assay Kits
- 5.2.2.1 Immuno assays
- 5.2.2.2 Cell based assays
- 5.2.3 Microplates
- 5.2.4 Others
5.3 Instruments
- 5.3.1 Microscopes
- 5.3.2 Flow cytometry
- 5.3.3 Spectrophotometers
- 5.3.4 qPCR
- 5.3.5 Cell Counters
- 5.3.6 HCS Systems
- 5.3.7 Cell Microarrays

6 GLOBAL CELL ANALYSIS MARKET, BY CELL TYPE

6.1 Overview
6.2 Human Cells
6.3 Animal Cells
6.4 Microbial Cells

7 GLOBAL CELL ANALYSIS MARKET, BY END-USER

7.1 Overview
7.2 Biotechnology Companies
7.3 Hospitals
7.4 Cell Banks
7.5 Others

8 GLOBAL CELL ANALYSIS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Argentina
8.6 Rest of the World
- 8.6.1 Middle East and Africa

9 GLOBAL CELL ANALYSIS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES

10.1 Becton, Dickinson and Company
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Merck KGAA
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Thermo Fisher Scientific, Inc.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Danaher Corporation
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 GE Healthcare
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Agilent Technologies, Inc.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Olympus Corporation
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Perkinelmer, Inc.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Promega Corporation
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Tecan Group Ltd.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments